Novavax’s 2024-2025 COVID-19 Vaccine Receives EUA for Use in the U.S.
Novavax, Inc. (Nasdaq: NVAX), a leading company in protein-based vaccines, has announced that its latest COVID-19 vaccine, the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705), ... Read More
New study suggests COVID-19 vaccines may have contributed to excess deaths in Western countries
A recent study published in BMJ Public Health has sparked controversy by suggesting that COVID-19 vaccines may have contributed to a rise in excess deaths ... Read More
AstraZeneca withdraws COVID-19 vaccine amid legal challenges and commercial decisions
In a significant development, UK-based pharmaceutical giant AstraZeneca has announced the global withdrawal of its COVID-19 vaccine, known as Covishield in India and Vaxzevria in ... Read More
Pfizer withdraws emergency use application for COVID-19 vaccine in India
US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in India. This decision comes after a series ... Read More